In vitro exposure of tobacco specific nitrosamines decreases the rat lung phospholipids by enhanced phospholipase A2 activity

Toxicology in Vitro

Volumn 28, Issue 6, 2014, Pages 1097-1105

  Vijayaraj, Panneerselvam ^a   Sivaprakasam, Chinnarasu ^a   Varthini, Lakshmanaperumal Vishnu ^a   Sarkar, Mary ^b   Nachiappan, Vasanthi ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Dipalmitoylphosphatidylcholine; Phospholipids; Pulmonary surfactant; Tobacco specific nitrosamines

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; LUNG SURFACTANT; NITROSAMINE; NITROSONORNICOTINE; PHOSPHATE P 32; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; N'-NITROSONORNICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; ISOTOPE LABELING; LIPID HYDROLYSIS; LUNG PARENCHYMA; MALE; NONHUMAN; PHOSPHOLIPID METABOLISM; PROTEIN EXPRESSION; RAT; TISSUE SLICE; TOBACCO; ANIMAL; DRUG EFFECTS; LUNG; METABOLISM; TOXICITY; WISTAR RAT;

ANIMALS; LUNG; MALE; NITROSAMINES; PHOSPHOLIPASES A2; PHOSPHOLIPIDS; RATS, WISTAR; TOBACCO;

EID: 84902104229     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.05.001     Document Type: Article

References (64)

1. Abe A.M., Hiraoka S., Wild S.E., Wilcoxen R., Paine I.I.I., Shayman J.A. Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 2004, 279:42605-42611.
2. Abraham E., Matthey M.A., Dinalello C.A. Consensus conference definitions for sepsis, septic shock, acute lung injury and acute respiratory distress syndrome. Crit. Care Med. 2000, 28:232-235.
3. Allen J.N., Moore S.A., Pope-Harman A.L., Marsh C.B., Wewers M.D. Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J. Lab. Clin. Med. 1995, 125:356-369.
4. Arbibe L., Vial D., Rosinski-Chupin I., Havet N., Huerre M., Vargaftig B.B., Touqui L. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 1997, 159:391-400.
5. Chao W., Spragg R.G., Smith R.M. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. J. Clin. Invest. 1995, 96:2654-2660.
6. Chen J., Higby R., Tian D., Tan D., Johnson M.D., Xiao Y., Kellar K.J., Feng S., Shields P.G. Toxicological analysis of low-nicotine and nicotine-free cigarettes. Toxicology 2008, 249:194-203.
7. Chilton F.H., Averill F.J., Hubbard W.C., Fonteh A.N., Triggiani M., Liu M.C. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 1996, 183:2235-2245.
8. Dawson R.M.C. The measurement of 32P labeling of individual kephalins and lecithin in a small sample of tissue. Biochim. Biophys. Acta 1954, 14:374-379.
9. Deberardinis R.J., Sayed N., Ditsworth D., Thompson C.B. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008, 18:54-61.
10. De Kanter R., De Jager M.H., Draaisma A.L., Jurva J.U., Olinga P., Meijer D.K., Groothuis G.M. Drug-metabolizing activity of human and rat liver, lung, kidney and intestine. Slices. Xenobiotica 2002, 32:349-362.
11. Dinh T.P., Freund T.F., Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem. Phys. Lipids 2002, 121:149-158.
12. Finley T.N., Ladman A.J. Low yield of pulmonary surfactant in cigarette smokers. N. Engl. J. Med. 1972, 286:223-227.
13. 2+- independent phospholipase A2 in synthesis of lung dipalmitoyl phosphatidylcholine. Am. J. Physiol. 1997, 272:238-243.
14. Fisher A.B., Dodia C., Feinstein S.I., Ho Y.S. Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J. Lipid Res. 2005, 46:1248-1256.
15. Folch J.M., Lees T., Sloane stanely G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-510.
16. 2. J. Biol. Chem. 1988, 263:11808-11813.
17. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta 1998, 1408:79-89.
18. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 1999, 13:1455-1476.
19. Griese M., Birrer P., Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur. Respir. J. 1997, 10:1983-1988.
20. Gunther A., Ruppert C., Schmidt R., et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2001, 2:353-364.
21. Haagsman H.P. Toxicological aspects of the surfactant system. Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 705-734. Elsevier, Amsterdam. B. Robertson, L. van Golde, J.J. Batenburg (Eds.).
22. Hamilton R.L., Goerke J., Guo L.S., Williams M.C., Havel R.J. Unilamellar liposomes made with the French pressure cell: a simple preparative and semiquantitative technique. J. Lipid Res. 1980, 21:981-992.
23. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 1998, 11:559-603.
24. Hite R.D., Seeds M.C., Jacinto R.B., Balasubramanian R., Waite M., Bass D. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2. Am. J. Physiol. 1998, 275:L740-L747.
25. Hite R.D., Seeds M.C., Bowton D.L., Grier B.L., Safta A.M., Balkrishnan R., Waite B.M., Bass D.A. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:610-617.
26. Hunninghake G.W., Crystal R.G. Cigarette smoking and lung destruction. Am Rev Respir Dis. 1983, 128:833-838.
27. Hurley B.P., McCormick B.A. Multiple roles of phospholipase A2 during lung infection and inflammation. Infect. Immun. 2008, 76:2259-2272.
28. IARC Monogr Smokeless tobacco and some tobacco-specific N-nitrosamines. Eval. Carcinog. Risks Hum. 2007, 89:1-592.
29. Kitsiouli E., Nakos G., Lekka M.E. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim. Biophys. Acta 2009, 1792:941-953.
30. Kremlev S.G., Unstead T.M., Phelps D.S. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J. Physiol. 1994, 267:L357-L364.
31. Lauren Kent., Lucy Smyth., Clayton Chris., Scott Laurie, Cook Ted., Stephens Richard., Fox Steve., Hext Peter., Farrow Stuart., Singh Dave. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 2008, 42:205-216.
32. LeVine A.M., Lotze A., Stanley C., Stroud O'Donnell R., Whitsett J., Pollack M.M. Surfactant content in children with inflammatory lung disease. Crit. Care Med. 1996, 24:1062-1067.
33. Lewis J.F., Jobe A.H. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1993, 147:218-233.
34. Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis. 2006, 9:230-234.
35. Lowry O.H., Rosebough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
36. Lusuardi M., Capelli A., Carli S., Tacconi M.T., Salmona M., Donner C.F. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 1992, 59:28-32.
37. Matute-Bello G., Liles W., Radella F. Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1997, 156:1969-1977.
38. Melck D., De Petrocellis L., Orlando P., Bisogno T., Laezza C., Bifulco M., Di Marzo V. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 2000, 141:118-126.
39. Melkamu T., Qian X., Upadhyaya P., O'Sullivan M.G., Kassie F. Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer. Vet. Pathol. 2013, 50:895-902.
40. Nachiappan V., Mufti S.I., Chakravarti A., Eskelson C.D., Rajasekharan R. Lipid peroxidation and ethanol-related tumor promotion in Fischer-344 rats treated with tobacco-specific nitrosamines. Alcohol Alcohol. 1994, 29:565-574.
41. Nomura D.K., Long J.Z., Niessen S., Hoover H.S., Ng S.W., Cravatt B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010, 140:49-61.
42. Obladen M. History of surfactant research. Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 1-18. Elsevier Science, Amsterdam. L.M.G. van Golde, J.J. Batenburg (Eds.).
43. 2 activity in the mouse lung. Am. J. Pathol. 1991, 138:195-202.
44. Oulton M.R., Janigan D.T., MacDonald J.M., Faulkner G.T., Scott J.E. Effects of smoke inhalation on alveolar surfactant subtypes in mice. Am. J. Pathol. 1994, 145:941-950.
45. Rau G., Dombrowsky H., Gebert A., Thole H., von Hardt H., Freihorst J., Bernhard W. Phosphatidylcholine metabolism of rat trachea in relation to lung parenchyma and surfactant. J. Appl. Physiol. 2003, 95:1145-1152.
46. Rioux N., Castonguay A. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB. Carcinogenesis 2000, 21:1745-1751.
47. Robert F., Jeanine D.A. The effect of cigarette smoke-derived oxidants on the inflammatory response of the lung. Clin. Appl. Immunol. Rev. 2006, 6:53-72.
48. Sabarirajan J., Vijayaraj P., Nachiappan V. Effect of lipopolysaccharide on alteration of phospholipids and their fatty acid composition in spleen and thymus by in vitro metabolic labeling. J. Appl. Toxicol. 2013, 33:418-425.
49. Sanderson M.J. Exploring lung physiology in health and disease with lung slices. Pulm. Pharmacol. Ther. 2011, 24:452-465.
50. Sauk J.J., Norris K. Tobacco components induce alterations in keratinocyte lipid membrane fluidity and inhibit cell proliferation in culture. J. Oral Pathol. 1988, 17:30-33.
51. Schuster G.S., Lubas S., Dirksen T.R., Erbland J.F. Lipids as factors in the cell response to tobacco components. Natl. Cancer Inst. Monogr. 1992, 2:191-201.
52. Schuster G.S., Caughman G.B., Dirksen T.R. Alteration of epithelial cell lipid synthesis by N-nitrosonornicotine. In Vitro Cell Dev. Bio. - Anim. 1995, 31:295-299.
53. Scott J.E. The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development. Tob. Induc. Dis. 2004, 2:3-25.
54. Seeds M.C., Grier B.L., Suckling B.N., Safta A.M., Long D.L., Waite B.M., Morris P.E., Hite R.D. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am. J. Med. Sci. 2012, 343:446-451.
55. Stinn W., Arts J.H., Buettner A., Duistermaat E., Janssens K., Kuper C.F., Haussmann H.J. Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. Toxicology 2010, 275:10-20.
56. Subramaniam S., Bummer P., Gairola C.G. Biochemical and biophysical characterization of pulmonary surfactant in rats exposed chronically to cigarette smoke. Fundam. Appl. Toxicol. 1995, 27:63-69.
57. Tonstad S., Johnston J.A. Cardiovascular risks associated with smoking: a review for clinicians. Eur. J. Cardiovascular Prev. Rehabilitation 2006, 13:507-514.
58. Touqui L., Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol. Med Today 1999, 5:244-249.
59. Vijayaraj P., Sabarirajan J., Nachiappan V. Enhanced phospholipase B activity and alteration of phospholipids and neutral lipids in Saccharomyces cerevisiae exposed to N-nitrosonornicotine. Antonie Van Leeuwenhoek 2011, 99:567-577.
60. Vijayaraj P., Sabarirajan J., Nachiappan V. Impaired phospholipid metabolism in Saccharomyces cerevisiae by increased phospholipase B activity induced by 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone. Toxicol. Environ. Chem. 2011, 93:700-714.
61. Wagner S., Paltauf F. Generation of glycerophospholipid molecular species in the yeast Saccharomyces cerevisiae. Fatty acid pattern of phospholipid classes and selective acyl turnover at sn-1 and sn-2 positions. Yeast 1994, 10:1429-1437.
62. Willers S., Attewell R., Bensryd I., Schutz A., Skarping A., Vahter M. Exposure to environmental tobacco smoke in the household and urinary cotinine excretion, heavy metals retention and lung function. Arch. Environ. Health 1992, 47:357-363.
63. Wirtz H.R., Schmidt M. Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur. Respir. J. 1996, 9:24-32.
64. Wright J.R., Wager R.E., Hawgood S., Dobbs L., Clements J.A. Surfactant apoprotein Mr=26,000-6,000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 1987, 262:2888-2894.